Nature

Nature, first published on 4 November 1869, is ranked the world s most cited interdisciplinary scientific journal by the Science Edition of the 2010 Journal Citation Reports. Most scientific journals are now highly specialized, and Nature is among the few journals (the other weekly journals Science and Proceedings of the National Academy of Sciences are also prominent examples) that still publish original research articles across a wide range of scientific fields. There are many fields of scientific research in which important new advances and original research are published as either articles or letters in Nature. Research scientists are the primary audience for the journal, but summaries and accompanying articles are intended to make many of the most important papers understandable to scientists in other fields and the educated general public. Towards the front of each issue are editorials, news and feature articles on issues of general interest to scientists, including current affairs, science funding, business, scientific ethics and research breakthroughs. There are also sections on books and arts. The remainder of the journal consists mostly of research articles, which are

Publisher
Nature Publishing Group
Country
United Kingdom
History
1869–present
Impact factor
36.101 (2010)
Some content from Wikipedia, licensed under CC BY-SA

Team finds new approach to curbing cancer cell growth

Using a new approach, scientists at The Scripps Research Institute (TSRI) and collaborating institutions have discovered a novel drug candidate that could be used to treat certain types of breast cancer, lung cancer and melanoma.

Mar 07, 2016
popularity182 comments 0

A deeper take on our sexual nature

The organs in our body may have a sexual identity of their own, new research suggests. The idea that our organs could be "male" or "female" raises the possibility that women and men may need different treatments as a result. ...

Feb 18, 2016
popularity215 comments 0

Targeting cancer proteins for degradation

Cancer research is increasingly focusing on therapeutic approaches in which disease causing proteins are marked for early degradation. Nicolas Thomä and his group at the Friedrich Miescher Institute for Biomedical Research ...

Feb 24, 2016
popularity53 comments 0